Autoantibodies in systemic lupus erythematosus

Area of Science:

• Immunology
• Autoimmunity
• Nephrology

Background:

• Autoantibodies play a critical role in the pathogenesis of various autoimmune diseases.
• Understanding the specificities and mechanisms of autoantibodies is crucial for diagnosis and treatment.
• Various autoantibodies, including anti-DNA, anti-P, anti-Ro/SS-A, antineutrophil cytoplasmic antibody, antinucleosome, and anti-beta 2-glycoprotein I, are implicated in distinct autoimmune conditions.

Purpose of the Study:

• To explore the mechanisms by which cationic germ line gene-encoded anti-DNA antibodies induce inflammatory lesions.
• To investigate the role of somatic mutation in the electrical charge of anti-DNA antibodies.
• To examine the diagnostic utility of various autoantibodies in differentiating autoimmune diseases.

Main Methods:

• Analysis of transgenic mouse models to study anti-DNA antibody nephrogenicity.
• Detection of anti-P autoantibodies in healthy children and their relation to other autoantibodies.
• Characterization of anti-Ro/SS-A antibody epitopes.
• Combined immunofluorescence and ELISA for antineutrophil cytoplasmic antibody detection.
• Correlation of antinucleosome antibodies with disease activity in systemic lupus erythematosus.
• T-cell receptor transfection studies to analyze nucleosomal autoepitope recognition.
• Assessment of IgG anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome.
• Evaluation of lupus anticoagulant activity related to anti-beta 2-glycoprotein I epitope specificity.
• Investigation of beta 2-glycoprotein I binding to apoptotic cells and macrophage clearance.
• Analysis of anti-A2/RA33 autoantibody epitope specificity in distinguishing connective tissue diseases.

Main Results:

• Cationic anti-DNA antibodies may cause inflammatory lesions and glomerular mesangial cell apoptosis.
• Nephrogenicity of anti-DNA in a mouse model depended on epidermal interleukin alpha expression.
• Anti-P autoantibodies are present in children but masked by IgG; some are a subset of antilymphocyte antibodies.
• Anti-Ro/SS-A antibodies recognize structurally unrelated conformational epitopes.
• Combined immunofluorescence and ELISA for antineutrophil cytoplasmic antibody showed 99.5% specificity for vasculitis in connective tissue diseases.
• Antinucleosome antibodies are prevalent in systemic lupus erythematosus and inversely correlate with plasma nucleosome levels.
• T-cell receptors specific for nucleosomal autoepitopes recognized these epitopes presented by antigen-presenting cells via MHC class II molecules.
• IgG anti-beta 2-glycoprotein I antibodies are significantly associated with thrombosis in antiphospholipid syndrome.
• Anti-beta 2-glycoprotein I epitope specificity influences lupus anticoagulant activity; beta 2-glycoprotein I facilitates apoptotic cell clearance by macrophages.
• Anti-A2/RA33 autoantibody recognizes an epitope distinguishing lupus/rheumatoid arthritis from mixed connective tissue disease.

Conclusions:

• Autoantibodies play diverse roles in autoimmune disease pathogenesis, from direct tissue damage to influencing immune cell interactions.
• Specific autoantibody profiles, such as antineutrophil cytoplasmic antibody and antinucleosome antibodies, are valuable diagnostic markers for conditions like vasculitis and systemic lupus erythematosus.
• Further research into autoantibody epitope specificities and their interactions with cellular processes like apoptosis is essential for understanding and managing autoimmune diseases.